维普中文期刊产品整合服务
1413篇 您的检索式:作者名="Jacobson S"
    题名 作者 年代 出处 被引量
1Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford 2010The Lancet2010,,9742:3
2Random Early Detection Gateways for Congestion Avoidance显示文摘Floyd S Jacobson V 0,,:3
3Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis显示文摘AIM To confirm previous conclusions on Saccharomyces cerevisiae(S. cerevisiae) CNCM I-3856 for irritable bowel syndrome(IBS) management.METHODS An individual patient data meta-analysis was performed on two randomized clinical trials studying the effect of S. cerevisiae CNCM I-3856 supplementation on gastrointestinal(GI) symptoms in IBS subjects. A total of 579 IBS subjects were included. Outcomes were the daily Likert scale scores of abdominal pain/discomfort and bloating [area under the curve(AUC) and weekly means], responder status, and bowel movements(stool frequency and consistency). Statistical analyses were conducted in Intent to Treat(ITT) population, IBS-C subjects and IBS-C subjects with an abdominal pain/discomfort score higher than or equal to 2 at baseline('IBS-C ≥ 2 subpopulation').RESULTS S. cerevisiae CNCM I-3856 significantly improved abdominal pain/discomfort and bloating during the second month of supplementation [AUC(W5-W8)]with improvement up to the minimal clinically relevant threshold of 10%: a 12.3% reduction of abdominal pain/discomfort in the ITT population compared to the Placebo group(P = 0.0134) has been observed. In the IBS-C ≥ 2 subpopulation, there were a 13.1% reduction of abdominal pain/discomfort and a 14.9% reduction of bloating compared to the Placebo group(P = 0.0194 and P = 0.0145, respectively). GI symptoms significantly decreased during supplementation but no statistical differences were reported between groups at the end of the supplementation period. Responder status was defined as a subject who experienced a decrease of 1 arbitrary unit(a.u.) or 50% of the abdominal discomfort score from baseline for at least 2 wk out of the last 4 wk of the study. A significant difference between groups was reported in the ITT population, when considering the first definition: subjects in the Active group had 1.510 higher odds to be a responder(reduction of 1 a.u. of abdominal pain/discomfort) compared with subjects in the Placebo group(P = 0.0240). At the end of supplementation period, stool consistency in the Active group of the ITT population was significantly improved and classified as 'normal' compared to Placebo(respectively 3.13 ± 1.197 a.u. vs 2.58 ± 1.020 a.u., P = 0.0003). Similar results were seen in the IBS-C ≥ 2 subpopulation(Active group: 3.14 ± 1.219 a.u. vs Placebo group: 2.59 ± 1.017 a.u., P = 0.0009).CONCLUSION This meta-analysis supports previous data linking S. cerevisiae I-3856 and improvement of GI symptoms, in IBS overall population and in the IBS-C and IBS-C ≥ 2 subpopulations.Amélie Cayzeele-Decherf Fanny Pélerin Sébastien Leuillet Benoit Douillard Béatrice Housez Murielle Cazaubiel Gunnard K Jacobson Peter Jüsten Pierre Desreumaux 2017World Journal of Gastroenterology2017,23,2:2
4Random early detection gateways for congestion avoidance 显示文摘Floyd S Jacobson V 1993IEEE/ACM Transactions on Networking1993,1,4:2
5A new low-meltingpoint aluminium braze显示文摘Jacobson D M Humpston G and Sangha S P S 1996Welding Journal1996,75,8:2
6Random early detection gateways for congestion avoidance显示文摘Floyd S Jacobson V 1993IEEE/ACM Transactions on Networking1993,1,4:2
7Random early detection gateways for congestion avoidance显示文摘Floyd S JACOBSON M 0,,:2
8A new low-melting-point aluminum braze显示文摘Jacobson D M Humpston G Sangha S P S 1996Welding Journal1996,,8:1
9Selective antagonism of the hepatic glucocorticoid receptor reduces hepatic glucose production显示文摘Edgerton D S Jacobson P B Opgenorth T Jet cd 2006Metabolism2006,55,9:1
10Random Early Detection Gateways for Congestion Avoidance显示文摘S Floyd V Jacobson 1993IEEE/ACM Trans on Networking1993,1,4:1
11Random Early Detection Gateways for Congestion Avoidance显示文摘Floyd S Jacobson V 1993IEEE ACM Transactions on Networking1993,1,4:1
12Random early detection gate- way for congestion avoidance 显示文摘FLOYD S JACOBSON V 1993IEEE/ACM Transac- tions on Networking1993,1,4:1
13Oxygen exchange kinetics of epitaxial PrBaCo2O5+δ thin films显示文摘KIM G WANG S JACOBSON A J 2006Appl Phys Lett2006,88,02:1
14Mixed dentition analysis for Asian-Americans显示文摘Lee-Chan S Jacobson BN Chwa KH 0,,03:1
15Meta-analysis of comparison of effectiv-eness of lowering apolipoprotein B ver- sus low-density lipoprotein cholesterol and non high-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trims 显示文摘ROBINSON J G WANG S JACOBSON T A 2012Am J Cardiol2012,110,10:1
16CRH deficiency impairs but does not block pituitaryadrenal responses to diverse stressors显示文摘Jacobson L Muglia L J Weninger S C 2000Neuroendocrinology2000,71,:1
17Random early detection gateways for congestion avoidance显示文摘Floyd S Jacobson V 1993IEEE ACM Transactions on Networking1993,,8:1
18Using laboratory experiments in public economics显示文摘Aim J Jacobson S 2007National Tax Journal2007,60,1:1
19Friction Behavior and Squeal Generation of Disc Brakes at Low Speeds显示文摘Eriksson M Jacobson S 2001Proceedings of the Institution of Mechanical Engineers Part D: Journal of Automobile Engineering2001,215,5:1
20Random Early Detection Gateways for Congestion Avoidance显示文摘Floyd S Jacobson V 1993IEEE/ACM Transactions on Networking1993,4,1:1
返回顶部 每页显示:
共71页 首页 上一页 第1页 下一页 末页 /71 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费